Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve

NCT00712140 is registered in ClinicalTrials.gov with Warwick Medical School as lead sponsor.

NCT NCT00712140
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00712140 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Persephone: Duration of Trastuzumab With Chemotherapy in Women With Early Stage Breast Cancer: Six Months Versus Twelve
Lead sponsor
Warwick Medical School
Phase
Phase 3
Overall status
Unknown status
Start date
October 31, 2007
Completion date
Not reported
Enrollment
4,000 (estimated)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer